Chapter/Section Purchase

Leave This Empty:

Global Atezolizumab Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Atezolizumab Product Introduction
1.2 Market by Type
1.2.1 Global Atezolizumab Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Use: Single Drug
1.2.3 Use: Chemotherapy Combination
1.3 Market by Application
1.3.1 Global Atezolizumab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Bladder Cancer
1.3.3 Lung Cancer
1.3.4 Advanced Triple-negative Breast Cancer
1.3.5 Head and Neck Cancer
1.3.6 Urothelial Carcinoma
1.3.7 Renal Cell Carcinoma
1.3.8 Hepatocellular Carcinoma (HCC)
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Atezolizumab Sales Estimates and Forecasts 2017-2028
2.2 Global Atezolizumab Revenue Estimates and Forecasts 2017-2028
2.3 Global Atezolizumab Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Atezolizumab Sales by Region
2.4.1 Global Atezolizumab Sales by Region (2017-2022)
2.4.2 Global Sales Atezolizumab by Region (2023-2028)
2.5 Global Atezolizumab Revenue by Region
2.5.1 Global Atezolizumab Revenue by Region (2017-2022)
2.5.2 Global Atezolizumab Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Atezolizumab Sales by Manufacturers
3.1.1 Global Top Atezolizumab Manufacturers by Sales (2017-2022)
3.1.2 Global Atezolizumab Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atezolizumab in 2021
3.2 Global Atezolizumab Revenue by Manufacturers
3.2.1 Global Atezolizumab Revenue by Manufacturers (2017-2022)
3.2.2 Global Atezolizumab Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Atezolizumab Revenue in 2021
3.3 Global Atezolizumab Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Atezolizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Atezolizumab Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Atezolizumab Sales by Type
4.1.1 Global Atezolizumab Historical Sales by Type (2017-2022)
4.1.2 Global Atezolizumab Forecasted Sales by Type (2023-2028)
4.1.3 Global Atezolizumab Sales Market Share by Type (2017-2028)
4.2 Global Atezolizumab Revenue by Type
4.2.1 Global Atezolizumab Historical Revenue by Type (2017-2022)
4.2.2 Global Atezolizumab Forecasted Revenue by Type (2023-2028)
4.2.3 Global Atezolizumab Revenue Market Share by Type (2017-2028)
4.3 Global Atezolizumab Price by Type
4.3.1 Global Atezolizumab Price by Type (2017-2022)
4.3.2 Global Atezolizumab Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Atezolizumab Sales by Application
5.1.1 Global Atezolizumab Historical Sales by Application (2017-2022)
5.1.2 Global Atezolizumab Forecasted Sales by Application (2023-2028)
5.1.3 Global Atezolizumab Sales Market Share by Application (2017-2028)
5.2 Global Atezolizumab Revenue by Application
5.2.1 Global Atezolizumab Historical Revenue by Application (2017-2022)
5.2.2 Global Atezolizumab Forecasted Revenue by Application (2023-2028)
5.2.3 Global Atezolizumab Revenue Market Share by Application (2017-2028)
5.3 Global Atezolizumab Price by Application
5.3.1 Global Atezolizumab Price by Application (2017-2022)
5.3.2 Global Atezolizumab Price Forecast by Application (2023-2028)
6 North America
6.1 North America Atezolizumab Market Size by Type
6.1.1 North America Atezolizumab Sales by Type (2017-2028)
6.1.2 North America Atezolizumab Revenue by Type (2017-2028)
6.2 North America Atezolizumab Market Size by Application
6.2.1 North America Atezolizumab Sales by Application (2017-2028)
6.2.2 North America Atezolizumab Revenue by Application (2017-2028)
6.3 North America Atezolizumab Market Size by Country
6.3.1 North America Atezolizumab Sales by Country (2017-2028)
6.3.2 North America Atezolizumab Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Atezolizumab Market Size by Type
7.1.1 Europe Atezolizumab Sales by Type (2017-2028)
7.1.2 Europe Atezolizumab Revenue by Type (2017-2028)
7.2 Europe Atezolizumab Market Size by Application
7.2.1 Europe Atezolizumab Sales by Application (2017-2028)
7.2.2 Europe Atezolizumab Revenue by Application (2017-2028)
7.3 Europe Atezolizumab Market Size by Country
7.3.1 Europe Atezolizumab Sales by Country (2017-2028)
7.3.2 Europe Atezolizumab Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Atezolizumab Market Size by Type
8.1.1 Asia Pacific Atezolizumab Sales by Type (2017-2028)
8.1.2 Asia Pacific Atezolizumab Revenue by Type (2017-2028)
8.2 Asia Pacific Atezolizumab Market Size by Application
8.2.1 Asia Pacific Atezolizumab Sales by Application (2017-2028)
8.2.2 Asia Pacific Atezolizumab Revenue by Application (2017-2028)
8.3 Asia Pacific Atezolizumab Market Size by Region
8.3.1 Asia Pacific Atezolizumab Sales by Region (2017-2028)
8.3.2 Asia Pacific Atezolizumab Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Atezolizumab Market Size by Type
9.1.1 Latin America Atezolizumab Sales by Type (2017-2028)
9.1.2 Latin America Atezolizumab Revenue by Type (2017-2028)
9.2 Latin America Atezolizumab Market Size by Application
9.2.1 Latin America Atezolizumab Sales by Application (2017-2028)
9.2.2 Latin America Atezolizumab Revenue by Application (2017-2028)
9.3 Latin America Atezolizumab Market Size by Country
9.3.1 Latin America Atezolizumab Sales by Country (2017-2028)
9.3.2 Latin America Atezolizumab Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Atezolizumab Market Size by Type
10.1.1 Middle East and Africa Atezolizumab Sales by Type (2017-2028)
10.1.2 Middle East and Africa Atezolizumab Revenue by Type (2017-2028)
10.2 Middle East and Africa Atezolizumab Market Size by Application
10.2.1 Middle East and Africa Atezolizumab Sales by Application (2017-2028)
10.2.2 Middle East and Africa Atezolizumab Revenue by Application (2017-2028)
10.3 Middle East and Africa Atezolizumab Market Size by Country
10.3.1 Middle East and Africa Atezolizumab Sales by Country (2017-2028)
10.3.2 Middle East and Africa Atezolizumab Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Overview
11.1.3 Genentech (Roche) Atezolizumab Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Genentech (Roche) Atezolizumab Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genentech (Roche) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Atezolizumab Industry Chain Analysis
12.2 Atezolizumab Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Atezolizumab Production Mode & Process
12.4 Atezolizumab Sales and Marketing
12.4.1 Atezolizumab Sales Channels
12.4.2 Atezolizumab Distributors
12.5 Atezolizumab Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Atezolizumab Industry Trends
13.2 Atezolizumab Market Drivers
13.3 Atezolizumab Market Challenges
13.4 Atezolizumab Market Restraints
14 Key Findings in The Global Atezolizumab Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer